Even retatrutide's lower doses (8 mg) outperformed semaglutide's best results
However, patients with chronic kidney disease (particularly stage 3 or higher or those with albuminuria) should follow ADA/KDIGO guidelines of approximately 0.8 g/kg/day unless otherwise directed by their nephrologist
Ingredients Aqua, Glycerin, Glycereth-26, Butylene Glycol, Methylpro Panediol, Vinyl Dimethicone, Niacinamide, 1-2-Hexanediol, Betaine, Isononyl Iso Nonanoate, Isohexadecane, Sodium Polyacrylate, Ammonium Acryloyldimethyltaurat/VP Copolymer, Phenyl Trimethicone, Dimethiconol, Perfum, Chondrus Crispus Powder, C18-21 Alkane, Glutathione, Ethylhexylglycerin, Polyglyceryl-10 Laurate, Glyceryl Acrylate/Acrylic Acid Copolymer, Agar, Xanthan Gum, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Adenosine, Tromethamine, Acrylates/C10-30 Alkyl, Acrylate Crosspolymer, Glucose, Limonene, Gellan Gum, Thioctic Acid, Caprylic/Capric Triglyceride, Citral, Ceramide NP, Sorbitan Laurate, Hydroxyethylcellulose, Acetyl Dipeptide-1 Cetylester, Palmitoyl Tripeptide-5, Acetyl Hexapeptide-1, Soluble Collagen The manufacturer is responsible for the products ingredients
Zach Zalewski examined the legal and regulatory position of compounders during shortages, and raised difficult questions about how to distinguish between compounding as a safeguard for patients and compounding as a commercial enterprise
